Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicardipine vs. Urapidil for Hemodynamic Stability during Gastrectomy
NCT03497351Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Apr 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nicardipine and urapidil in hypertension (HTN), sponsored by Chinese PLA General Hospital. Primary endpoint: Stroke Volume Variation. Started Apr 2018; status: completed.
02
Drugs
nicardipineurapidil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03497351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03497351.